ποΈ Verified NIH Record β’ Updated 2026-06-15
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar (NCT07337590)
π’ Recruiting Observational / Diagnostic βοΈ Medical Device Protocol Sponsor: Exero Medical Ltd.
π©Ί Plain-English Summary (8th-Grade Level)
Purpose: To evaluate the effect of xBar system utilization on clinical outcomes during recovery following colorectal surgery.
Who can join: Review the eligibility criteria below.
Location: University of Louisville Hospital β Louisville, Kentucky
Age range: 21 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (6 Sites)
- University of Louisville Hospital β Louisville, Kentucky
- Johns Hopkins University β Baltimore, Maryland
- Bryan Medical Center β Lincoln, Nebraska
- Weill Cornell Medicine Colon and Rectal Surgery β New York, New York
- Department of Colon and Rectal Surgery β New York, New York
- Allegheny Health Network β Pittsburgh, Pennsylvania
π Contact the Study Coordinator
Phone: +972547545065
Email: ilana.fishman@exeromedical.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Cancer
- Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes β Los Angeles, California
- A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors β Duarte, California
- Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) β Houston, Texas
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver β Basking Ridge, New Jersey
- The PRIME-CRC Trial to Promote CRC Screening in Rural Communities β Bastrop, Louisiana
- Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer β Concord, California
Explore by condition: All Colorectal Cancer clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.